Cite Filings / BOLT / 0001564590-21-059379

Feed Companies Filings Check

Sign in

8-K

Current Report

Bolt Biotherapeutics, Inc. Filed 2021-12-06 Acc 0001564590-21-059379

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , bolt-8k_20211206.htm

Around this filing

2021-12-16 8-K Executive or director change
2021-12-09 4 Chief Financial Officer bought 6,256 shares at an average $7.04 ($44,067)
2021-12-06 8-K Regulation FD disclosure
2021-11-29 SC 13G Amended Statement of Ownership
2021-11-19 8-K Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading bolt-8k_20211206.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…